DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
Condition: Type 2 Diabetes Mellitus Interventions: Drug: 50mg group; Drug: 100mg group; Drug: 200mg group; Drug: placebo group Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials